+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

One of Hillary Clinton's top advisers said Clinton would make the crucial change to marijuana the DEA just passed on

Aug 13, 2016, 02:35 IST

Hillary Clinton.David Becker/Getty Images

Advertisement

One of Hillary Clinton's top senior policy advisers said that the Democratic presidential nominee would reschedule marijuana if she gets elected in November.

Marijuana is currently a Schedule I drug on the Controlled Substances Act, meaning that there are no accepted medical uses for the plant, and it has a high potential for abuse.

"We applaud the steps taken today by the Obama Administration to remove research barriers that have significantly limited the scientific study of marijuana," Maya Harris, a senior policy adviser to Clinton's campaign, said in a statement obtained by The Cannabist.

Harris continued (emphasis ours):

Advertisement

The comments came as a reaction to Thursday's announcement that the Drug Enforcement Administration would not reschedule marijuana as many had expected.

Moving marijuana to Schedule II would allow medical practitioners to prescribe it to patients across the US.

However, there are still doubts in the marijuana industry about whether moving the plant to Schedule II would actually be a positive development.

"Moving cannabis to Schedule II doesn't address the social harms of prohibition," Patrick Moen, a managing director at Privateer Holdings (a cannabis-focused private equity company), and a former DEA agent himself, told Business Insider. "It also doesn't create a proper mechanism for patients who need access today."

Seibo Shen, the CEO of VapeXhale, a vaporizer company, told Business Insider in an email that rescheduling marijuana is a "double-edged sword," because it would "put the industry completely in the hands of big pharma companies."

Advertisement

Some lawmakers, like Earl Blumenauer, a democratic congressman from Oregon, say that moving marijuana to Schedule II doesn't go far enough.

"Americans have spoken, with a majority supporting full legalization," Blumenauer said in a statement. "It's not enough to remove some barriers to medical research. Marijuana shouldn't be listed as Schedule I; it shouldn't be listed at all."

NOW WATCH: 'I don't even really know where to start on answering this question': Watch President Obama respond to Trump's claim that the election will be rigged

Please enable Javascript to watch this video
Next Article